| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14737159.2015.1051529 |
| P698 | PubMed publication ID | 26027684 |
| P2093 | author name string | Ronald J Wapner | |
| Karen Wou | |||
| Joe Leigh Simpson | |||
| Jessica L Feinberg | |||
| P2860 | cites work | DNA Sequencing versus Standard Prenatal Aneuploidy Screening | Q22250872 |
| Isolation of fetal DNA from nucleated erythrocytes in maternal blood | Q24558688 | ||
| Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum | Q24567463 | ||
| Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci | Q24632266 | ||
| Fetal cells in the maternal circulation: feasibility for prenatal diagnosis | Q33650187 | ||
| DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
| Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
| Prenatal detection of fetal triploidy from cell-free DNA testing in maternal blood | Q34378350 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy | Q34418944 | ||
| Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes | Q34452242 | ||
| Georg Schmorl on trophoblasts in the maternal circulation | Q34566588 | ||
| Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis | Q35209735 | ||
| Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Q35552815 | ||
| Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe | Q35899367 | ||
| Chromosomal microarray versus karyotyping for prenatal diagnosis | Q36546668 | ||
| Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? | Q36787475 | ||
| Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma | Q37000915 | ||
| Noninvasive fetal genome sequencing: a primer | Q37056703 | ||
| The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis | Q37306246 | ||
| Turning the pyramid of prenatal care | Q37851291 | ||
| Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis | Q38178293 | ||
| The promise of fetal cells in maternal blood | Q38467937 | ||
| Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. | Q40028555 | ||
| Microarray-based cell-free DNA analysis improves noninvasive prenatal testing | Q40222706 | ||
| Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology | Q40775838 | ||
| Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing | Q41060187 | ||
| Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology | Q41609597 | ||
| Combined screening for preeclampsia and small for gestational age at 11-13 weeks. | Q43823700 | ||
| Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? | Q43943228 | ||
| Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma | Q44554684 | ||
| Uptake of noninvasive prenatal testing at a large academic referral center | Q44999703 | ||
| Cell-free DNA analysis for noninvasive examination of trisomy | Q46784231 | ||
| First-trimester or second-trimester screening, or both, for Down's syndrome | Q46799629 | ||
| Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing | Q46877513 | ||
| Noninvasive prenatal testing: limitations and unanswered questions | Q47622449 | ||
| Fetal cells in maternal blood: current and future perspectives. | Q50876400 | ||
| Enrichment of fetal trophoblast cells from the maternal peripheral blood followed by detection of fetal deoxyribonucleic acid with a nested X/Y polymerase chain reaction. | Q51032871 | ||
| Non-invasive early prenatal molecular diagnosis using retrieved transcervical trophoblast cells. | Q51041376 | ||
| Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
| Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Trophoblast retrieval and isolation from the cervix (TRIC) for noninvasive prenatal screening at 5 to 20 weeks of gestation | Q58803674 | ||
| Use of the Y Chromosome in Prenatal Sex Determination | Q59074357 | ||
| Fetal Nucleated Red Blood Cell Counts in Peripheral Blood of Mothers Bearing Down Syndrome Fetus | Q59135276 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 989-998 | |
| P577 | publication date | 2015-05-31 | |
| P1433 | published in | Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare | Q15756305 |
| P1476 | title | Cell-free DNA versus intact fetal cells for prenatal genetic diagnostics: what does the future hold? | |
| P478 | volume | 15 |
| Q39756897 | Gestation related karyotype, QF-PCR and CGH-array failure rates in diagnostic amniocentesis. |
| Q36943659 | The impact of genomics on health outcomes, quality, and safety. |
| Q52613197 | Trophoblast retrieval and isolation from the cervix: origins of cervical trophoblasts and their potential value for risk assessment of ongoing pregnancies. |
Search more.